MHD population mineral bone metabolism disorder
Conditions
Interventions
Control group:Conventional treatment
Sponsors
Shijiazhuang kidney disease hospital limited liability company
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. aged 18-55 years; 2. meet the diagnostic criteria of uremia, and dialysis treatment time more than 3 months; 3. blood IPTH> 300pg/ml, P> 1.78mmol/L; 4. signed informed consent, Voluntarily cooperate with all research steps.
Exclusion criteria
Exclusion criteria: 1. recent moxibustion local skin infection, scar or tumor were associated with diabetes and blood glucose control is not ideal; 2. the occurrence of serious complications, such as heart failure; 3. patients with primary hyperparathyroidism, secondary hyperparathyroidism, menopausal women, delayed nutrition compensatory disease and other causes of metabolic bone disease; 4. patient compliance is poor, can not be prescribed Medication and affect the efficacy of those who judge; 5. patient with incomplete information, unable to determine the efficacy; 6. complicated with other diseases, need to accept long term immunosuppressive therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood phosphorus; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood calcium;iPTH; | — |
Countries
China
Contacts
Public ContactTang Junting
Shijiazhuang kidney disease hospital limited liability company
Outcome results
None listed